# RDF representation of pubmed9202001.bel as produced by bel2rdf
# (https://github.com/OpenBEL/bel2rdf) with schema statements removed:

@base <http://www.selventa.com/bel/> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

<bp_GO_G1/S_transition_of_mitotic_cell_cycle> a belv:Term,
     belv:BiologicalProcess;
   rdfs:label "bp(GO:\"G1/S transition of mitotic cell cycle\")";
   belv:hasConcept <namespace/go/G1/S%20transition%20of%20mitotic%20cell%20cycle> .

<bp_GO_G2/M_transition_of_mitotic_cell_cycle> a belv:Term,
     belv:BiologicalProcess;
   rdfs:label "bp(GO:\"G2/M transition of mitotic cell cycle\")";
   belv:hasConcept <namespace/go/G2/M%20transition%20of%20mitotic%20cell%20cycle> .

<bp_GO_regulation_of_apoptotic_process> a belv:Term,
     belv:BiologicalProcess;
   rdfs:label "bp(GO:\"regulation of apoptotic process\")";
   belv:hasConcept <namespace/go/regulation%20of%20apoptotic%20process> .

<complex_NCM_p85/p110_PI3Kinase_Complex> a belv:Term,
     belv:ComplexAbundance;
   rdfs:label "complex(NCM:\"p85/p110 PI3Kinase Complex\")";
   belv:hasConcept <namespace/selventa-named-complexes-mouse/p85/p110%20PI3Kinase%20Complex> .

<kin_complex_NCM_p85/p110_PI3Kinase_Complex> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(complex(NCM:\"p85/p110 PI3Kinase Complex\"))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <complex_NCM_p85/p110_PI3Kinase_Complex> .

<kin_p_MGI_Ptk2> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(p(MGI:Ptk2))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <p_MGI_Ptk2> .

<kin_p_PFM_Akt_Family> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(p(PFM:\"Akt Family\"))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <p_PFM_Akt_Family> .

<kin_p_PFM_Mapk_JNK_Family> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(p(PFM:\"Mapk JNK Family\"))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <p_PFM_Mapk_JNK_Family> .

<kin_p_PFM_Mapk_p38_Family> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(p(PFM:\"Mapk p38 Family\"))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <p_PFM_Mapk_p38_Family> .

<p_HGNC_CCNB1> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(HGNC:CCNB1)";
   belv:hasConcept <namespace/hgnc-approved-symbols/CCNB1> .

<p_HGNC_KRAS_sub_G_12_C> a belv:Term,
     belv:ProteinVariantAbundance;
   rdfs:label "p(HGNC:KRAS,sub(G,12,C))";
   belv:hasChild <p_HGNC_KRAS> .

<p_HGNC_KRAS_sub_G_12_C_causesNoChange_path_MESHD_Neoplasms> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,C)) causesNoChange path(MESHD:Neoplasms)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """We found that the K12V oncogene induces a more aggressive\
tumorigenic phenotype than the K12D oncogene, whereas K12C does not induce\
tumors in this model.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_C_causesNoChange_path_MESHD_Neoplasms>];
   belv:hasObject <path_MESHD_Neoplasms>;
   belv:hasRelationship belv:causesNoChange;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_C> .

<p_HGNC_KRAS_sub_G_12_D_causesNoChange_complex_p_HGNC_KRAS_p_MGI_Raf1> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) causesNoChange complex(p(HGNC:KRAS),p(MGI:Raf1))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Unexpectedly, in tumors induced by the K12D oncogene,\
the K-Ras mutant protein does not interact with Raf-1 nor activates\
the Erk canonical pathway.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_causesNoChange_complex_p_HGNC_KRAS_p_MGI_Raf1>];
   belv:hasObject <complex_p_HGNC_KRAS_p_MGI_Raf1>;
   belv:hasRelationship belv:causesNoChange;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_causesNoChange_kin_p_PFM_MAPK_Erk1/3_Family> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) causesNoChange kin(p(PFM:\"MAPK Erk1/3 Family\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Unexpectedly, in tumors induced by the K12D oncogene,\
the K-Ras mutant protein does not interact with Raf-1 nor activates\
the Erk canonical pathway.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_causesNoChange_kin_p_PFM_MAPK_Erk1/3_Family>];
   belv:hasObject <kin_p_PFM_MAPK_Erk1/3_Family>;
   belv:hasRelationship belv:causesNoChange;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_kin_complex_NCM_p85/p110_PI3Kinase_Complex> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> kin(complex(NCM:\"p85/p110 PI3Kinase Complex\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Instead, it transduces signals through the PI3K/Akt, JNK,
p38 and FAK pathways.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_kin_complex_NCM_p85/p110_PI3Kinase_Complex>];
   belv:hasObject <kin_complex_NCM_p85/p110_PI3Kinase_Complex>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_kin_p_MGI_Ptk2> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> kin(p(MGI:Ptk2))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Instead, it transduces signals through the PI3K/Akt, JNK,
p38 and FAK pathways.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_kin_p_MGI_Ptk2>];
   belv:hasObject <kin_p_MGI_Ptk2>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Akt_Family> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> kin(p(PFM:\"Akt Family\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Instead, it transduces signals through the PI3K/Akt, JNK,
p38 and FAK pathways.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Akt_Family>];
   belv:hasObject <kin_p_PFM_Akt_Family>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Mapk_JNK_Family> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> kin(p(PFM:\"Mapk JNK Family\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Instead, it transduces signals through the PI3K/Akt, JNK,
p38 and FAK pathways.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Mapk_JNK_Family>];
   belv:hasObject <kin_p_PFM_Mapk_JNK_Family>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Mapk_p38_Family> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> kin(p(PFM:\"Mapk p38 Family\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Instead, it transduces signals through the PI3K/Akt, JNK,
p38 and FAK pathways.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_kin_p_PFM_Mapk_p38_Family>];
   belv:hasObject <kin_p_PFM_Mapk_p38_Family>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_D_increases_path_MESHD_Neoplasms> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D)) -> path(MESHD:Neoplasms)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """We found that the K12V oncogene induces a more aggressive\
tumorigenic phenotype than the K12D oncogene, whereas K12C does not induce\
tumors in this model.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_D_increases_path_MESHD_Neoplasms>];
   belv:hasObject <path_MESHD_Neoplasms>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_D> .

<p_HGNC_KRAS_sub_G_12_V_causesNoChange_bp_GO_regulation_of_apoptotic_process> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) causesNoChange bp(GO:\"regulation of apoptotic process\")";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_causesNoChange_bp_GO_regulation_of_apoptotic_process>];
   belv:hasObject <bp_GO_regulation_of_apoptotic_process>;
   belv:hasRelationship belv:causesNoChange;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_directlyIncreases_complex_p_HGNC_KRAS_p_MGI_Raf1> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) => complex(p(HGNC:KRAS),p(MGI:Raf1))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """A molecular analysis of the induced tumors shows that\
the K12V mutant protein interacts with Raf-1 and transduces signals mainly through the Erk pathway.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_directlyIncreases_complex_p_HGNC_KRAS_p_MGI_Raf1>];
   belv:hasObject <complex_p_HGNC_KRAS_p_MGI_Raf1>;
   belv:hasRelationship belv:directlyIncreases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> bp(GO:\"G1/S transition of mitotic cell cycle\")";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_bp_GO_G1/S_transition_of_mitotic_cell_cycle>];
   belv:hasObject <bp_GO_G1/S_transition_of_mitotic_cell_cycle>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_bp_GO_G2/M_transition_of_mitotic_cell_cycle> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> bp(GO:\"G2/M transition of mitotic cell cycle\")";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_bp_GO_G2/M_transition_of_mitotic_cell_cycle>];
   belv:hasObject <bp_GO_G2/M_transition_of_mitotic_cell_cycle>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_kin_p_PFM_MAPK_Erk1/3_Family> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> kin(p(PFM:\"MAPK Erk1/3 Family\"))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """A molecular analysis of the induced tumors shows that\
the K12V mutant protein interacts with Raf-1 and transduces signals mainly through the Erk pathway.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_kin_p_PFM_MAPK_Erk1/3_Family>];
   belv:hasObject <kin_p_PFM_MAPK_Erk1/3_Family>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_CCNB1> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> p(HGNC:CCNB1)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_CCNB1>];
   belv:hasObject <p_HGNC_CCNB1>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_PCNA> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> p(HGNC:PCNA)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_PCNA>];
   belv:hasObject <p_HGNC_PCNA>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_RB1_pmod_P> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> p(HGNC:RB1,pmod(P))";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """Finally, the higher growth rate of the K12V tumors associates\
with enhanced Rb phosphorylation, and PCNA and cyclin B upregulation, consistent\
with faster G1/S and G2/M transitions, without alteration of apoptotic\
regulation.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_p_HGNC_RB1_pmod_P>];
   belv:hasObject <p_HGNC_RB1_pmod_P>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_increases_path_MESHD_Neoplasms> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) -> path(MESHD:Neoplasms)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/10090>,
       <annotation/cell-line/3T3-Swiss%20albino>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """We found that the K12V oncogene induces a more aggressive\
tumorigenic phenotype than the K12D oncogene, whereas K12C does not induce\
tumors in this model.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_increases_path_MESHD_Neoplasms>];
   belv:hasObject <path_MESHD_Neoplasms>;
   belv:hasRelationship belv:increases;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_prognosticBiomarkerFor_path_MESHD_Neoplasm_Metastasis> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) prognosticBiomarkerFor path(MESHD:\"Neoplasm Metastasis\")";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/9606>,
       <annotation/disease/Colorectal%20Neoplasms>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """K-Ras Asp12 (K12D) is more prevalent in benign than in\
malignant human colorectal tumors, whereas K-Ras Val12 (K12V) associates\
with more advanced and metastatic carcinomas, higher recurrence and\
decreased survival.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_prognosticBiomarkerFor_path_MESHD_Neoplasm_Metastasis>];
   belv:hasObject <path_MESHD_Neoplasm_Metastasis>;
   belv:hasRelationship belv:prognosticBiomarkerFor;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_KRAS_sub_G_12_V_prognosticBiomarkerFor_path_MESHD_Recurrence> a belv:Statement;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V)) prognosticBiomarkerFor path(MESHD:Recurrence)";
   belv:hasEvidence [ a belv:Evidence;
     belv:hasAnnotation <annotation/species-taxonomy-id/9606>,
       <annotation/disease/Colorectal%20Neoplasms>;
     belv:hasCitation <http://bio2rdf.org/pubmed:16679305>;
     belv:hasEvidenceText """K-Ras Asp12 (K12D) is more prevalent in benign than in\
malignant human colorectal tumors, whereas K-Ras Val12 (K12V) associates\
with more advanced and metastatic carcinomas, higher recurrence and\
decreased survival.""";
     belv:hasStatement <p_HGNC_KRAS_sub_G_12_V_prognosticBiomarkerFor_path_MESHD_Recurrence>];
   belv:hasObject <path_MESHD_Recurrence>;
   belv:hasRelationship belv:prognosticBiomarkerFor;
   belv:hasSubject <p_HGNC_KRAS_sub_G_12_V> .

<p_HGNC_PCNA> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(HGNC:PCNA)";
   belv:hasConcept <namespace/hgnc-approved-symbols/PCNA> .

<p_HGNC_RB1> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(HGNC:RB1)";
   belv:hasConcept <namespace/hgnc-approved-symbols/RB1> .

<p_HGNC_RB1_pmod_P> a belv:Term,
     belv:ModifiedProteinAbundance;
   rdfs:label "p(HGNC:RB1,pmod(P))";
   belv:hasChild <p_HGNC_RB1>;
   belv:hasModificationType belv:Phosphorylation .

<p_MGI_Ptk2> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(MGI:Ptk2)";
   belv:hasConcept <namespace/mgi-approved-symbols/Ptk2> .

<p_MGI_Raf1> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(MGI:Raf1)";
   belv:hasConcept <namespace/mgi-approved-symbols/Raf1> .

<p_PFM_Akt_Family> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(PFM:\"Akt Family\")";
   belv:hasConcept <namespace/selventa-protein-families-mouse/Akt%20Family> .

<p_PFM_MAPK_Erk1/3_Family> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(PFM:\"MAPK Erk1/3 Family\")";
   belv:hasConcept <namespace/selventa-protein-families-mouse/MAPK%20Erk1/3%20Family> .

<p_PFM_Mapk_JNK_Family> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(PFM:\"Mapk JNK Family\")";
   belv:hasConcept <namespace/selventa-protein-families-mouse/Mapk%20JNK%20Family> .

<p_PFM_Mapk_p38_Family> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(PFM:\"Mapk p38 Family\")";
   belv:hasConcept <namespace/selventa-protein-families-mouse/Mapk%20p38%20Family> .

<path_MESHD_Neoplasm_Metastasis> a belv:Term,
     belv:Pathology;
   rdfs:label "path(MESHD:\"Neoplasm Metastasis\")";
   belv:hasConcept <namespace/mesh-diseases/Neoplasm%20Metastasis> .

<path_MESHD_Recurrence> a belv:Term,
     belv:Pathology;
   rdfs:label "path(MESHD:Recurrence)";
   belv:hasConcept <namespace/mesh-diseases/Recurrence> .

<complex_p_HGNC_KRAS_p_MGI_Raf1> a belv:Term,
     belv:ComplexAbundance;
   rdfs:label "complex(p(HGNC:KRAS),p(MGI:Raf1))";
   belv:hasChild <p_HGNC_KRAS>,
     <p_MGI_Raf1> .

<kin_p_PFM_MAPK_Erk1/3_Family> a belv:Term,
     belv:AbundanceActivity;
   rdfs:label "kin(p(PFM:\"MAPK Erk1/3 Family\"))";
   belv:hasActivityType belv:Kinase;
   belv:hasChild <p_PFM_MAPK_Erk1/3_Family> .

<path_MESHD_Neoplasms> a belv:Term,
     belv:Pathology;
   rdfs:label "path(MESHD:Neoplasms)";
   belv:hasConcept <namespace/mesh-diseases/Neoplasms> .

<p_HGNC_KRAS> a belv:Term,
     belv:ProteinAbundance;
   rdfs:label "p(HGNC:KRAS)";
   belv:hasConcept <namespace/hgnc-approved-symbols/KRAS> .

<p_HGNC_KRAS_sub_G_12_D> a belv:Term,
     belv:ProteinVariantAbundance;
   rdfs:label "p(HGNC:KRAS,sub(G,12,D))";
   belv:hasChild <p_HGNC_KRAS> .

<p_HGNC_KRAS_sub_G_12_V> a belv:Term,
     belv:ProteinVariantAbundance;
   rdfs:label "p(HGNC:KRAS,sub(G,12,V))";
   belv:hasChild <p_HGNC_KRAS> .
